Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ciprofloxacin otic solution - SALVAT

Next Previous
X
Search
Drug Profile

Ciprofloxacin otic solution - SALVAT

Alternative Names: 0.2% Ciprofloxacin otic solution - SALVAT; 0.3% Ciprofloxacin otic solution - SALVAT; CETRAXAL; CETRAXAL OTICO; DF-289; InfectoCipro; Ototopical ciprofloxacin; Unicexal

Latest Information Update: 04 Dec 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SALVAT
  • Class Anti-infectives; Antibacterials; Carboxylic acids; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules
  • Mechanism of Action DNA topoisomerase IV inhibitors; Type II bacterial DNA topoisomerase inhibitors; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Otitis externa; Otitis media

Most Recent Events

  • 11 Feb 2019 Ciprofloxacin otic solution is not yet available in Iceland for Otitis externa
  • 31 Aug 2015 No development reported - Phase-III for Otitis media (In children) in Spain, Denmark, Finland and Sweden (Otic)
  • 01 Jun 2013 SALVAT completes a phase III trial in Otitis media (in children) in Denmark, Finland, Spain and Sweden (NCT01404611)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top